United States Securities and Exchange Commission · EDGAR Accession 0001508594-26-000002

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 1508594
Period 2024-12-31

THC Farmaceuticals, Inc.

CorporationUTIncorporated 2005Thousand Oaks, CAcbdg.com
B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 5%2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income2,47614,976▼ 83%
Total assets2,740,1452,745,097▼ 0%
Cash & equivalents1,7141,714
Accounts receivable11,35011,350
Short-term debt142,095142,095
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer.